Pharma Fermentation: India's Next Biomanufacturing Opportunity
India, July 1 -- image credit- freepik
According to IMARC Group, the India fermentation chemicals market reached $3.2 billion in 2025 and is projected to grow to $5.5 billion by 2034, exhibiting a CAGR of 5.79 per cent during 2026-2034. However, growth alone will not guarantee leadership. India's ability to build a robust domestic fermentation ecosystem, reduce import dependence, and scale advanced biomanufacturing capabilities will determine whether it can emerge as a global fermentation hub.
Pharma fermentation refers to the use of microorganisms such as bacteria, yeast, and fungi in controlled bioreactors to produce pharmaceutical products, ingredients, and biologics. Several fermentation methodologies are used across the pharmaceuti...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.